Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.
about
A MALDI-MSI Approach to the Characterization of Radiation-Induced Lung Injury and Medical Countermeasure DevelopmentMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsRadiation countermeasure agents: an update (2011-2014)The H-ARS Dose Response Relationship (DRR): Validation and Variables.Delayed Effects of Acute Radiation Exposure in a Murine Model of the H-ARS: Multiple-Organ Injury Consequent to <10 Gy Total Body Irradiation.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion.
P2860
Q28386213-822A6421-5018-42C6-AC39-CD7DEC9781C3Q28817576-D63CAC9F-ACD1-4A30-82F4-638AFCF263C2Q35626587-95EF428D-5A31-4C74-BC26-75C544EACE47Q36120987-4F9A634E-C9C2-4E90-95B2-16C9F764F4A5Q36121012-34735159-4223-4C52-94B1-FC3A05F78BF3Q39398444-D99C3634-8B0F-4C22-A0A6-81B60DB3B320Q47657705-06EEF971-7D99-43DF-9DAF-DAF1F70D9536Q48227806-8C74BB1A-1FEA-4153-BCB2-63C497CF30E6
P2860
Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Survival efficacy of the PEGyl ...... w damage in treated survivors.
@en
Survival efficacy of the PEGyl ...... w damage in treated survivors.
@nl
type
label
Survival efficacy of the PEGyl ...... w damage in treated survivors.
@en
Survival efficacy of the PEGyl ...... w damage in treated survivors.
@nl
prefLabel
Survival efficacy of the PEGyl ...... w damage in treated survivors.
@en
Survival efficacy of the PEGyl ...... w damage in treated survivors.
@nl
P2093
P2860
P1433
P1476
Survival efficacy of the PEGyl ...... w damage in treated survivors.
@en
P2093
Barry P Katz
Carol H Sampson
Christie M Orschell
Gilbert W Carnathan
Hui Lin Chua
Keith Lenden
P Artur Plett
Thomas J MacVittie
P2860
P356
10.1097/HP.0B013E3182A4DF10
P407
P577
2014-01-01T00:00:00Z